A doctor is online now – good chance of an appointment today
Home · Blog · Is Wegovy working for me?

How do you know if Wegovy is working for you?

When you start on Wegovy (semaglutide), the changes happen gradually, and in the first weeks many people think: I am not losing weight on Wegovy. Your body needs time, and the studies show what you can look out for.

Adam Omari Licensed doctor and medical director, Recepta

Published 15 November 2026 · Reading time 3 min.

Short answer

You know Wegovy is working for you when your appetite drops and your weight starts to go down during the first months. In one study, 88% had lost at least 5% of their weight after 20 weeks. A slow start is not a bad sign: those who started slowly and continued also lost weight.

When can you tell if Wegovy is working?

You can usually tell if Wegovy is working within the first 20 weeks: your appetite drops first, and your weight follows.

The first signs are often less appetite and feeling full sooner. Wegovy is stepped up over 16 weeks to a maintenance dose (the fixed dose) of 2.4 mg once a week. So you are only on the full dose after about 4 months.[3]

A later analysis of the STEP 4 study shows what this means for your weight. 88% had lost at least 5% of their weight after 20 weeks on Wegovy, and that group ended up with an average weight loss of 19.7% after 68 weeks.[1]

What if you lose weight slowly on Wegovy at first?

Slow weight loss at the start of Wegovy does not mean the treatment is not working, as long as you continue.

In the same analysis, those who had lost less than 5% after 20 weeks but continued ended up at 6.4% after 68 weeks. Those who switched to placebo (an inactive dummy treatment) ended up at 0.3%. The researchers conclude that a good start predicts a good result, while a slow start says only a little about how things end.[1]

Weight loss after 68 weeks on Wegovy, by how the first 20 weeks went
Good startat least 5% after 20 weeks
19.7%
Slow start, continuedless than 5% after 20 weeks
6.4%
Slow start, switched to placebo
0.3%

Later analysis of the STEP 4 study, presented as a conference abstract in 2021. The figures apply to participants who stayed on treatment.[1]

The pattern is the same for Mounjaro (tirzepatide). In a later analysis of the SURMOUNT-1 study from 2025, 18% had lost less than 5% after 12 weeks. Of these, 70% reached at least 5% by week 24, and 90% by week 72.[2]

When does the doctor assess whether Wegovy should continue?

The doctor assesses on an ongoing basis whether Wegovy should continue, based on your weight, your appetite and your side effects, not on a single measurement.

The official EU guidance (the summary of product characteristics) for Wegovy has no fixed stopping rule for adults. For adolescents, it says that treatment should be stopped and reassessed if BMI (the ratio between weight and height) has not fallen by at least 5% after 12 weeks on 2.4 mg or the highest dose the young person can tolerate. For Mounjaro there is no such rule.[3][4]

At Recepta the first doctor consultation is free, and the doctor follows up every 4 weeks. Talk to the doctor before you change anything yourself.

Read also: How big is the risk that Wegovy or Mounjaro won't work? · What happens when you stop Wegovy or Mounjaro?

Questions and answers about when Wegovy works

What are the first signs that Wegovy is working?
The first signs that Wegovy is working are often less appetite and feeling full sooner when you eat. You often notice these changes before the weight loss itself.
How long does the dose escalation of Wegovy take?
The dose escalation of Wegovy takes 16 weeks, until you reach the maintenance dose of 2.4 mg once a week. So you are only on the full dose after about 4 months.
Is there a rule for when adults should stop Wegovy?
No, the EU summary of product characteristics for Wegovy has no fixed stopping rule for adults. The doctor assesses the course of treatment based on weight, appetite and side effects.

Sources

  1. Mosenzon O, Garvey WT, Hesse D, et al. Clinically-relevant weight loss is achieved independently of early weight loss response to once-weekly subcutaneous semaglutide 2.4 mg (STEP 4). Journal of the Endocrine Society 2021;5(Supplement 1). Conference abstract. doi.org
  2. Ard J, Lee CJ, Gudzune K, et al. Weight reduction over time in tirzepatide-treated participants by early weight loss response: post hoc analysis in SURMOUNT-1. Diabetes, Obesity and Metabolism 2025;27(9):5064-5071. doi.org
  3. European Medicines Agency (EMA): Summary of product characteristics for Wegovy (semaglutide), sections 4.1 and 4.2. ema.europa.eu
  4. European Medicines Agency (EMA): Summary of product characteristics for Mounjaro (tirzepatide). ema.europa.eu

Would you like to know if medical weight loss is right for you?

A licensed Danish doctor assesses which treatment suits you. The consultation is free, and you only pay once the doctor has approved treatment.

Prescription medicine is only prescribed after the doctor's individual assessment.

This post is general information and does not replace a medical assessment. Never stop or switch medication on your own. Recepta is a doctor's clinic that treats patients with this type of medication, among others. If you have questions about a treatment you are already on, write to your doctor on My page. If you have acute symptoms, contact your own doctor, the out-of-hours doctor service (lægevagten) or call 112.